 Todos Medical Ltd has said it is preparing for the commercial launch of a urinary tract infection UTI PCR assay after its lab Provista Diagnostics completed validation of a 27-pathogen precision medicine panel. The company said the assay is currently in production, and Provista intends to target skilled nursing facilities, OB-GYN and womens health specialists as primary customers. 